Having trouble viewing this email? Click here

Advancing and protecting our clients' interests in the pharmacy benefit marketplace for more than 20 years.
DRUGS APPROVED Drugs Can Reach Patients Faster and Cheaper, FDA Chief Says FDA sets approval path for Prosensa muscle disorder drug GE Healthcare Announces FDA Approval of Invenia™ Automated Breast Ultrasound System (ABUS) for Enhanced Patient Experience and More Accurate Diagnosis than Mammography Alone in Women with Dense Breasts FDA approves first generic versions of celecoxib FDA approves drug to treat MRSA	SUMMARY OF TOP ARTICLES - JUNE 5, 2014 Targeted drugs on the rise Washington Post - June 2, 2014 New treatments aimed at narrow subsets of diseases Antiplatelet Drug Delay Hikes Stent Death Risk MedPage Today - May 28, 2014 Nearly one in three patients in a Canadian province failed to fill a prescription for clopidogrel in the days after receiving a coronary stent, and over the next month these patients suffered heart attacks at three times the rate and died at five times the rate of patients who promptly filled their prescriptions for the drug, researchers reported. SNRI Equal to Hormones for Hot Flush Tx MedPage Today - May 27, 2014 A low dose of the antidepressant venlafaxine (Effexor) appeared roughly as good as hormonal therapy to ease hot flushes in menopause, a randomized trial showed. Compound 'may form basis of Alzheimer's prevention drug' Medical News Today - June 4, 2014 A newly identified compound, 2-PMAP, has been found to reduce levels of Alzheimer's-associated amyloid proteins by more than half in animal studies. Researchers hope that this could be developed into a safe preventive treatment for humans. CVS Caremark Launches Innovative Specialty Connect™ Program at all CVS/pharmacy Locations PRNewswire - May 28, 2014 Program offers choice and flexibility to improve the specialty patient experience and deliver superior health outcomes. Nonprescription Nexium Heartburn Medicine Launches Associated Press - May 27, 2014 A nonprescription version of Nexium, the most popular medicine for frequent, severe heartburn, has just gone on sale. Federal court vacates 340B rule regarding orphan drugs Lexology - June 2, 2014 On May 23, 2014, the U.S. District Court for the District of Columbia issued a Memorandum Opinion in Pharmaceutical Research and Manufacturers of America v. United States Department of Health and Human Services, et al. At issue in the case was a regulation related to the purchase of orphan drugs by certain hospital entities participating in the 340B Federal Drug Pricing Program. The court vacated the regulation and held that the federal government did not have the requisite authority to implement such a rule. HHS announces the availability of $300 Million in Affordable Care Act funds to expand services at the Nation’s community health centers U.S. Department of Health & Human Services - June 3, 2014 Health and Human Services (HHS) Secretary Kathleen Sebelius today announced the availability of up to $300 million under the Affordable Care Act to help the nation’s community health centers expand service hours, hire more medical providers, and add oral health, behavioral health, pharmacy, and vision services. 340B Comes Under Fire During House E&C Health Subcommittee Hearing Safety Net Hospitals for Pharmaceutical Access (SNHPA) - May 23, 2014 Three influential members of Congress—Reps. Renee Ellmers (R-N.C.), Tim Murphy (R-Pa.), and Bill Cassidy (R-La.)—voiced concerns about the 340B program during a House Energy and Commerce Health Subcommittee hearing yesterday, May 21. 25 States Now Part of Drug Monitoring Program SourceMedia - May 30, 2014 Twenty-five states are now participating in the National Association of Boards of Pharmacy PMP InterConnect program, the NABP's prescription drug monitoring initiative. Contact, Kristin LaVitola Marketing Director, PSG Pharmaceutical Strategies Group (PSG) Office: 972-244-8388 Email: KLavitola@PSGConsults.com PSGNewsletter@PSGConsults.com www.PSGConsults.com